Global InformationAbagovomab information
 | |
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Mouse |
| Target | (imitates CA-125) |
| Clinical data | |
| Pregnancy category |
|
| Routes of administration | subcutaneous |
| ATC code |
|
| Pharmacokinetic data | |
| Bioavailability | N/A |
| Excretion | N/A |
| Identifiers | |
| CAS Number |
|
| ChemSpider |
|
| UNII |
|
  (what is this?) (verify) | |
Abagovomab is a mouse anti-idiotype monoclonal antibody whose variable epitope mirrors a tumour antigen (CA-125) highly expressed in the epithelial ovarian cancer. Abagovomab does not bind directly to CA-125, but it works as a "surrogate" antigen, enabling the immune system to identify and attack tumour cells displaying the CA-125 protein. Through this, it is hoped that the body's immune system may be able to combat any remaining individual tumour cells and thus prevent recurrence of the disease.[medical citation needed]